Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Importation Blocked But Not Forgotten As User Fee Bill Clears Senate Cmte

Executive Summary

Amendment from Sen. Sanders was tabled in part to avoid adding a controversial provision that could slow the bill's passage, but may be debated during upcoming drug costs hearing.

Advertisement

Related Content

Democrats’ Drug Pricing Bills Echo Trump Ideas But Broad Republican Support Unlikely
Democrat-Controlled House Will Turn Up The Volume On Drug Pricing
Democrat-Controlled House Will Turn Up The Volume On Drug Pricing
Sen. Cassidy Suggests Importing Generics From EU To Pressure US Prices
Sen. Cassidy Suggests Importing Generics From EU To Pressure US Prices
Drug Pricing Hearing In Senate Postponed, Handing Innovators Another Victory
FDA User Fee Bill: House Cmte. Makes Technical Changes, Adds Pricing Resolution
The US Drug Pricing Hearing Pharma Wants
The US Drug Pricing Hearing Pharma Wants
User Fee Bill Caught In Comey Firing Tidal Wave

Topics

Advertisement
UsernamePublicRestriction

Register

PS120623

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel